Ketoconazole (R 41 400) in the Treatment of Dermatophyte Infections A Clinical, Mycological, and Morphological Study

ABSTRACT: Ketoconazole (100 mg, orally, once daily) was investigated in nine patients with extensive dermatophyte infections. After treatment ranging between one week and three months, clinical cures (healing of lesions and negative cultures) were observed in all cases. In vitro growth of Trichophyton rubrum, T. mentagrophytes, and T. verrucosum isolated from infected skin scales were completely inhibited by concentrations of ketoconazole of 10 μg/ml and above. No evidence for the development of drug resistance was obtained from regular in vitro sensitivity tests.

[1]  M. Borgers Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. , 1980, Reviews of infectious diseases.

[2]  H. van den Bossche,et al.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis , 1980, Antimicrobial Agents and Chemotherapy.

[3]  M. Borgers,et al.  The Activity of Ketoconazole in Mixed Cultures of Fungi and Human Fibroblasts: Die Wirkung von Ketoconazol in Mischkulturen von Pilzen und menschlichen Fibroblasten , 1980, Mykosen.

[4]  J. Hanifin,et al.  Oral ketoconazole therapy for griseofulvin-resistant dermatophytosis , 1980 .

[5]  F. Odds,et al.  The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. , 1980, The Journal of antimicrobial chemotherapy.

[6]  M. De Brabander,et al.  Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. , 1979, Postgraduate medical journal.

[7]  R. Hay Failure of treatment in chronic dermatophyte infections. , 1979, Postgraduate medical journal.

[8]  D. Stevens,et al.  Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. , 1979, Postgraduate medical journal.

[9]  J. V. van Cutsem,et al.  Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. , 1979, European journal of obstetrics, gynecology, and reproductive biology.

[10]  D. Bibel,et al.  Interactions of Trichophyton mentagrophytes and micrococci on skin culture. , 1979, The Journal of investigative dermatology.

[11]  A. Espinel-Ingroff,et al.  Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. , 1978, The Journal of infectious diseases.

[12]  R. Hutton,et al.  Scanning electron microscopy of experimental Trichophyton mentagrophytes infections in guinea pig skin , 1978, Infection and immunity.

[13]  H. Preusser,et al.  Econazole effects on Trichophyton rubrum and Candida albicans--electron microscopic and cytochemical studies. , 1978, Mykosen. Supplement.

[14]  M. Dorn,et al.  Onychomykose: Licht‐und Rasterelektronenmikroskopie * , 1977 .

[15]  M. Borgers,et al.  An Ultrastructural and Cytochemical Study of Candida aIbicans after in Vitro Treatment with Imidazoles , 1976, Mykosen.

[16]  A. Rook THE INTERNATIONAL SOCIETY OF TROPICAL DERMATOLOGY , 1975 .

[17]  J. V. van Cutsem,et al.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. , 1972, Chemotherapy.

[18]  A. Tosti,et al.  Contribution to the knowledge of dermatophytic invasion of hair. An investigation with the scanning electron microscope. , 1970, The Journal of investigative dermatology.